Boston Scientific Corp (XTER:BSX)
€ 86.5 -0.5 (-0.57%) Market Cap: 126.52 Bil Enterprise Value: 134.81 Bil PE Ratio: 74.93 PB Ratio: 6.45 GF Score: 79/100

Boston Scientific Corp at Sanford C Bernstein Strategic Decisions Conference Transcript

May 29, 2019 / 12:00PM GMT
Unidentified Analyst

Great. Well, good morning, everybody, and welcome to SDC. We are thrilled this morning to have Mike Mahoney, CEO of Boston Scientific. Mike -- we've got question cards around the tables so feel free to fill them out, and we'll bring them up here and fit them in as we can. Mike is going to kick us off with just a few introductory remarks and then we'll jump into the Q&A.

Michael F. Mahoney
Boston Scientific Corporation - Chairman, President & CEO

Good morning, everyone. We're better than Boeing and McDonald's. I'm glad you showed up at our conference room. This growth, less controversy. Just I've been with the company for 8 years now and very -- we have our Investor Day coming up in -- what, Susie? A month or so, 45 days. We'll talk about the future of the company during that Investor Day conference as well as a bit here. But the company is doing extremely well. We've really transformed the company over those 8 years from a turnaround where we used to grow kind of at market to where we're consistently growing well-above market. Really our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot